What is the sensitivity of mammography and dynamic MR imaging for DCIS if the whole-breast histopathology is used as a reference standard?;Sensibilità della mammografia e della RM a contrasto dinamico per le lesioni neoplastiche non invasive della mammella: Confronto con reference standard istologico dell'intera mammella

Radiologia Medica

Volumn 113, Issue 3, 2008, Pages 439-451

  Sardanelli, F ^a   Bacigalupo, L ^b   Carbonaro, L ^a   Esseridou, A ^a   Giuseppetti, G M ^c   Panizza, P ^d   Lattanzio, V ^e   Del Maschio, A ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b HÔPITAL SAINT ELOI   (France)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e POLICLINICO   (Italy)

Author keywords

Breast; Ductal carcinoma in situ (DCIS); Dynamic magnetic resonance (MR) imaging; Mammography

Indexed keywords

ADULT; ARTICLE; BREAST CARCINOMA; CANCER PATIENT; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; RANK SUM TEST;

ADULT; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CONTRAST MEDIA; FEMALE; HETEROCYCLIC COMPOUNDS; HUMANS; ITALY; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 44249099879     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-008-0250-0     Document Type: Article

References (72)

1. Arpino G, Laucirica R, Elledge RM (2005) Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med 143:446-457
2. Lakhani SR (1999) The transition from hyperplasia to invasive carcinoma of the breast. J Pathol 187:272-278
3. Ottesen GL, Graversen HP, Blichert-Toft M et al (1993) Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group. Am J Surg Pathol 17:14-21
4. Haagensen CD (1986) Lobular neoplasia, lobular carcinoma in situ. In: Haagensen CD (ed) Diseases of the breast. 3rd ed. Saunders, Philadelphia, pp 192-241
5. Leonard GD, Swain SM (2004) Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 96:906-920
6. Collins LC, Tamimi RM, Baer HJ et al (2005) Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study. Cancer 103:1778-1784
7. Tavassoli FA, Devilee P (2003) Tumours of the breast and female genital organs. IARC Press-World Health Organization
8. Chuba PJ, Hamre MR, Yap J et al (2005) Bilateral risk for subsequent breast cancer after lobular carcinomain-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol 23:5534-5541
9. Bibeau F, Borrelly C, Chateau MC et al (2005) Recent data on lobular neoplasia of the breast: the pathologist's opinion. Bull Cancer 92:453-458
10. Bartow SA, Pathak DR, Black WC et al (1987) Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer 60:2751-2760
11. Alpers CE, Wellings SR (1985) The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum Pathol 16:796-807
12. Colleau M, Magalon G, Bonnier P (2005) Breast carcinoma diagnosed from surgical specimens. Retrospective study on three years. Ann Chir Plast Esthet 50:127-133
13. Welch HG, Black WC (1997) Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann Intern Med 127:1023-1028
14. Shiraishi A, Kurosaki Y, Maehara T et al (2003) Extension of ductal carcinoma in situ: histopathological association with MR imaging and mammography. Magn Reson Med Sci 2:159-63
15. Ernster VL, Barclay J (1997) Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. J Natl Cancer Inst Monogr 22:151-156
16. Ernster VL, Ballard-Barbash R, Barlow WE et al (2002) Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94:1546-1554
17. Feuer EJ, Wun LM (1992) How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach. Am J Epidemiol 136:1423-1436
18. Ward BA, McKhann CF, Ravikumar TS (1992) Ten-year follow-up of breast carcinoma in situ in Connecticut. Arch Surg 127:1392-1395
19. Bush DS, Remington PL, Reeves M, Phillips JL (1994) In situ breast cancer correlates with mammography use, Wisconsin: 1980-1992. Wis Med J 93:483-484
20. Stomper PC, Connolly JL, Meyer JE, Harris JR (1989) Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiologic-pathologic correlation. Radiology 172:235-241
21. Frykberg ER (1999) Lobular carcinoma of the breast. Breast J 5:296-302
22. Beute BJ, Kalisher L, Hutter RVP (1991) Lobular carcinoma in situ of the breast: clinical, pathologic, and mammographic features. AJR Am J Roentgenol 157:257-265
23. Stein LF, Zisman G, Rapelyea JA et al (2005) Lobular carcinoma in situ of the breast presenting as a mass. AJR Am J Roentgenol 184:1799-1801
24. Cutuli B, de Lafontan B, Quetin P, Mery E (2005) Breast-conserving surgery and radiotherapy: a possible treatment for lobular carcinoma in situ? Eur J Cancer 41:380-385
25. Georgian-Smith D, Lawton TJ (2001) Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. Am J Roentgenol 176:1255-1259
26. Middleton LP, Grant S, Stephens T et al (2003) Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Mod Pathol 16:120-129
27. Orel S, Medonca MH, Reynolds C et al (1997) MR imaging of ductal carcinoma in situ. Radiology 202:413-420
28. Gilles R, Guinebretiere JM, Lucidarme O et al (1994) Nonpalpable breast tumors: diagnosis with contrastenhanced subtraction dynamic MR imaging. Radiology 191:625-631
29. Gilles R, Meunier M, Lucidarme O et al (1996) Clustered breast microcalcifications: evaluation by dynamic contrast-enhanced subtraction MRI. J Comput Assist Tomogr 20:9-14
30. Harms SE, Flamig DP, Hesley KL et al (1993) MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 187:493-501
31. Stomper PC, Herman S, Klippenstein DL et al (1995) Suspect breast lesions: findings at dynamic gadoliniumenhanced MR imaging correlated with mammographic and pathologic features. Radiology 197:387-395
32. Hulka CA, Smith BL, Sgroi DC et al (1995) Benign and malignant breast lesions: differentiation with echo-planar MR imaging. Radiology 197:33-38
33. Bone B, Aspelin P, Bronge L et al (1996) Sensitivity and specificity of MR mammography with histopathological correlation in 250 breasts. Acta Radiol 37:208-213
34. Fobben ES, Rubin CZ, Kalisher L et al (1995) Breast MR imaging with commercially available techniques: radiologic-pathologic correlation. Radiology 196:143-152
35. Teifke A, Hlawatsch A, Beier T et al (2002) Undetected malignancies of the breast: dynamic contrast enhanced MR imaging at 1.0 T. Radiology 224:881-888
36. Gilles R, Zafrani B, Guinebretiere JM et al (1995) Ductal carcinoma in situ: MR imaging-histopathologic correlation. Radiology 196:415-419
37. Soderstrom CE, Harms SE, Copit DS et al (1996) 3D RODEO breast MRI of lesions containing ductal carcinoma in situ. Radiology 201:427-432
38. Boetes C, Strijk SP, Holland R et al (1997) False-negative MR imaging of malignant breast tumors. Eur Radiol 7:1231-1234
39. Viehweg P, Lampe D, Buchmann J, Heywang-Kobrünner SH (2000) In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast enhanced MR imaging. MAGMA 11:129-137
40. Heywang-Kobrunner SH, Viehweg P et al (1997) Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 24:94-108
41. Tesoro-Tess JD, Amusoro A, Rovini D et al (1995) Microcalcifications in clinically normal breasts: the value of high field, surface coil, Gd-DTPA enhanced MRI. Eur Radiol 5:417-422
42. Neubauer H, Li M, Kuehne-Heid R et al (2003) High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement. BJR 76:3-12
43. Fischer U, Westerhof JP, Brinck U et al (1996) Ductal carcinoma in situ in dynamic MR-mammography at 1.5. Rofo 164:290-294
44. Fischer U, Kopka L, Grabbe E (1999) Breast carcinoma: effect of the preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 231:881-888
45. Zuiani C, Francescutti GE, Londero V et al (2002) Ductal carcinoma in situ: is there a role for MRI? J Exp Clin Cancer Res 21[Suppl 3]:89-95
46. Bazzocchi M, Zuiani C, Panizza P et al (2006) Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial. AJR Am J Roentgenol 186:1723-32
47. Del Maschio A, Bazzocchi M, Giuseppetti GM et al (2002) RM mammaria. Rapporto sul Trial nazionale multicentrico delle Sezioni di Studio di Risonanza Magnetica e Senologia. Radiol Med 104:262-272
48. Sardanelli F, Giuseppetti GM, Panizza P et al (2004) Sensitivity of MR vs. mammography for detecting foci of multifocal/multicentric breast cancer in fatty and dense breasts using the whole breast pathologic examination as a gold standard. AJR Am J Roentgenol 183:1149-1157
49. [No authors listed] (1983) Cancer statistics in developing countries: report on a WHO meeting, Nagoya, Japan, 18-22 August, 1981. World Health Stat Q 36:213-217
50. Baum F, Fischer U, Vosshenrich R, Grabbe E (2002) Classification of hypervascularized lesions in CE MR imaging of the breast. Eur Radiol 12:1087-1092
51. Holland R, Hendriks JH (1994) Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol 11:181-192
52. Elling D, Vesper AS, Fiedler B et al (2001) Intraductal component in invasive breast cancer: analysis of 250 resected surgical specimens. Breast 10:405-410
53. Berg WA, Gutierrez L, NessAiver MS et al (2004) Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233:830-849
54. Hwang ES, Kinkel K, Esserman LJ et al (2003) Magnetic resonance imaging in patients diagnosed with ductal carcinoma-in-situ: value in the diagnosis of residual disease, occult invasion, and multicentricity. Ann Surg Oncol 10:381-388
55. Menell JH, Morris EA, Dershaw DD et al (2005) Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 11:382-390
56. Dershaw DD, Abramson A, Kinne DW (1989) Ductal carcinoma in situ: mammographic findings and clinical implications. Radiology 170:411-415
57. Evans A, Pinder S, Wilson R et al (1994) Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings. Am J Roentgenol 162:1307-1311
58. Westerhof JP, Fischer U, Moritz JD, Oestmann JW (1998) MR imaging of mammographically detected clustered calcifications: is there any value? Radiology 207:675-681
59. Liberman L, Morris EA, Dershaw DD et al (2003) Ductal enhancement on MR imaging of the breast. AJR Am J Roentgenol 181:519-525
60. Liberman L, Morris EA, Lee M et al (2002) Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol 179:171-178
61. Van Goethem M, Schelfout K, Kersschot E et al (2005) Comparison of MRI features of different grades of DCIS and invasive carcinoma of the breast. JBR-BTR 88:225-232
62. Morakkabati-Spitz N, Leutner C, Schild H et al (2005) Diagnostic usefulness of segmental and linear enhancement in dynamic breast MRI. Eur Radiol 15:2010-2017
63. Bluemke DA, Gatsonis CA, Chen MH et al (2004) Magnetic resonance imaging of the breast prior to biopsy. JAMA 292:2735-2742
64. Ottinetti A, Sapino A (1988) Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesions. Breast Cancer Res Treat 11:241-248
65. Tilanus-Linthorst MM, Obdeijn IMM, Bartels KC et al (2000) First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 63:53-60
66. Kriege M, Brekelmans CT, Boetes C et al (2004) Efficacy of magnetic resonance imaging and mammography for breast cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427-437
67. Warner E, Plewes DB, Hill KA et al (2004) Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 292:1317-1325
68. Leach MO, Boggis CR, Dixon AK et al (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365:1769-1778
69. Kuhl CK, Schrading S, Leutner CC et al (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469-8476
70. Sardanelli F, Podo F, D'Agnolo G et al (2007) Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT Study): Interim Results. Radiology 242:698-715
71. Sardanelli F, Podo F (2007) Breast MR imaging in women at high risk of breast cancer. Is something changing in early breast cancer detection? Eur Radiol 17:873-887
72. Kuhl CK, Schrading S, Bieling HB, et al (2007) MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 370:485-492